Infectious Disease

Infectious disease tests are one of the most dynamic spaces in the in vitro diagnostics (IVD) industry. Global market growth is a product of new disease threats as well as the introduction and clinical acceptance of routine screening procedures. The diversified market space promotes demand for novel diagnostic technologies such as PCR-alternative molecular amplification methods, next-generation sequencing (NGS), and mass spectrometry. The $17 billion+ global infectious disease diagnostics market also includes larger established segments in immunoassays and ID/AST.

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: Apr 21, 2017 | Price: $0.00
A brief look at molecular test products for Zika, Ebola and other infectious disease and a discussion of the the Infectious Disease Diagnostics market generally.  Based on Kalorama Information's World Molecular Diagnostics Market full report....
Published: Feb 26, 2016 | Price: $4,200.00
Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health...
Published: Nov 1, 2015 | Price: $3,500.00
The World Market for Infectious Disease Diagnostic Tests World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing...
Published: May 7, 2014 | Price: $995.00
Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern. These infection may...
Published: Aug 9, 2013 | Price: $3,995.00
This  Kalorama Information report  The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment. Given the cost of hospital-acquired and...
Published: Aug 14, 2012 | Price: $3,995.00
A nosocomial, or hospital-acquired, infection is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at...
Published: Feb 1, 2012 | Price: $3,800.00
This Kalorama Information report – The World Market for Anti-Infectives - focuses on three key segments of treatment: Antifungals (Allylamines, Azoles, Polyene Macrolides, Other Antifungals) Antibacterials (Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones,...
Published: Oct 1, 2011 | Price: $150.00
The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus...
Published: Jul 1, 2011 | Price: $150.00
A hospital-acquired infection (HAI)is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are...
Published: Mar 25, 2011 | Price: $150.00
The Asian vaccine market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from these emerging vaccine markets. The population of nearly 4 billion people throughout Asia accounts for more than half of the...
Published: Oct 1, 2009 | Price: $3,500.00
The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more...
Published: May 1, 2009 | Price: $250.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama...
Published: Apr 1, 2009 | Price: $995.00
The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion...
Published: Jan 1, 2009 | Price: $3,500.00
A nosocomial, or hospital-acquired, infection is a new infection that is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, This type of infection is also known as a hospital-acquired infection (or more generically...
Published: Aug 1, 2008 | Price: $1,500.00
Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside...
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.